Histogenics Corp (NASDAQ:HSGX)’s share price was up 5.9% during trading on Monday . The company traded as high as $0.18 and last traded at $0.18. Approximately 3,583,650 shares were traded during mid-day trading, a decline of 65% from the average daily volume of 10,373,892 shares. The stock had previously closed at $0.17.
Institutional investors have recently modified their holdings of the company. Geode Capital Management LLC acquired a new position in shares of Histogenics during the 4th quarter worth $25,000. Virtu Financial LLC increased its stake in shares of Histogenics by 505.8% during the 1st quarter. Virtu Financial LLC now owns 592,976 shares of the biotechnology company’s stock worth $69,000 after purchasing an additional 495,096 shares during the last quarter. Finally, Sabby Management LLC acquired a new position in shares of Histogenics during the 1st quarter worth $220,000. Institutional investors and hedge funds own 7.97% of the company’s stock.
COPYRIGHT VIOLATION WARNING: “Histogenics (HSGX) Trading Up 5.9%” was originally reported by Baseball Daily News and is the sole property of of Baseball Daily News. If you are accessing this story on another domain, it was illegally stolen and reposted in violation of United States and international trademark and copyright legislation. The original version of this story can be accessed at https://www.baseballdailydigest.com/news/2019/05/22/histogenics-hsgx-trading-up-5-9.html.
Histogenics Company Profile (NASDAQ:HSGX)
Histogenics Corporation develops restorative cell therapies that would offer rapid-onset pain relief and restored function. The company was founded in 2000 and is headquartered in Waltham, Massachusetts.
Featured Article: Moving Average – How it Helps Investors in Stock Selection
Receive News & Ratings for Histogenics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Histogenics and related companies with MarketBeat.com's FREE daily email newsletter.